ALFAVISION S | BALAXI PHARMA | ALFAVISION S/ BALAXI PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -14.5 | -120.9 | - | View Chart |
P/BV | x | 1.0 | 3.7 | 27.9% | View Chart |
Dividend Yield | % | 0.4 | 0.0 | - |
ALFAVISION S BALAXI PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ALFAVISION S Mar-23 |
BALAXI PHARMA Mar-23 |
ALFAVISION S/ BALAXI PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 42 | 706 | 5.9% | |
Low | Rs | 10 | 304 | 3.3% | |
Sales per share (Unadj.) | Rs | 18.6 | 330.5 | 5.6% | |
Earnings per share (Unadj.) | Rs | -0.7 | 45.2 | -1.5% | |
Cash flow per share (Unadj.) | Rs | -0.7 | 46.9 | -1.4% | |
Dividends per share (Unadj.) | Rs | 0.05 | 0 | - | |
Avg Dividend yield | % | 0.2 | 0 | - | |
Book value per share (Unadj.) | Rs | 13.7 | 169.5 | 8.1% | |
Shares outstanding (eoy) | m | 31.53 | 10.18 | 309.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.4 | 1.5 | 90.9% | |
Avg P/E ratio | x | -37.6 | 11.2 | -336.0% | |
P/CF ratio (eoy) | x | -38.4 | 10.8 | -356.8% | |
Price / Book Value ratio | x | 1.9 | 3.0 | 63.1% | |
Dividend payout | % | -7.3 | 0 | - | |
Avg Mkt Cap | Rs m | 813 | 5,139 | 15.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 290 | 0.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 586 | 3,364 | 17.4% | |
Other income | Rs m | 0 | 26 | 0.2% | |
Total revenues | Rs m | 586 | 3,391 | 17.3% | |
Gross profit | Rs m | 27 | 574 | 4.6% | |
Depreciation | Rs m | 0 | 18 | 2.8% | |
Interest | Rs m | 48 | 14 | 346.2% | |
Profit before tax | Rs m | -22 | 569 | -3.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 110 | 0.1% | |
Profit after tax | Rs m | -22 | 460 | -4.7% | |
Gross profit margin | % | 4.5 | 17.1 | 26.6% | |
Effective tax rate | % | -0.5 | 19.3 | -2.8% | |
Net profit margin | % | -3.7 | 13.7 | -27.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 542 | 1,935 | 28.0% | |
Current liabilities | Rs m | 50 | 531 | 9.5% | |
Net working cap to sales | % | 83.8 | 41.7 | 200.9% | |
Current ratio | x | 10.7 | 3.6 | 294.7% | |
Inventory Days | Days | 749 | 2 | 35,995.0% | |
Debtors Days | Days | 3,041 | 567 | 536.2% | |
Net fixed assets | Rs m | 1,507 | 462 | 326.5% | |
Share capital | Rs m | 62 | 102 | 60.8% | |
"Free" reserves | Rs m | 371 | 1,624 | 22.8% | |
Net worth | Rs m | 433 | 1,726 | 25.1% | |
Long term debt | Rs m | 1,565 | 9 | 17,983.9% | |
Total assets | Rs m | 2,048 | 2,397 | 85.5% | |
Interest coverage | x | 0.5 | 42.3 | 1.3% | |
Debt to equity ratio | x | 3.6 | 0 | 71,719.1% | |
Sales to assets ratio | x | 0.3 | 1.4 | 20.4% | |
Return on assets | % | 1.3 | 19.8 | 6.4% | |
Return on equity | % | -5.0 | 26.6 | -18.8% | |
Return on capital | % | 1.3 | 33.6 | 3.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 802 | 0.0% | |
Fx outflow | Rs m | 0 | 40 | 0.0% | |
Net fx | Rs m | 0 | 763 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 26 | 61 | 42.0% | |
From Investments | Rs m | -160 | -106 | 151.5% | |
From Financial Activity | Rs m | 127 | 255 | 49.7% | |
Net Cashflow | Rs m | -8 | 210 | -3.7% |
Indian Promoters | % | 24.8 | 66.9 | 37.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 17.2 | - | |
FIIs | % | 0.0 | 17.2 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 75.2 | 33.1 | 226.9% | |
Shareholders | 2,884 | 5,206 | 55.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ALFAVISION S With: ADANI ENTERPRISES REDINGTON MMTC SAT INDUSTRIES SIRCA PAINTS INDIA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ALFAVISION S | BALAXI PHARMA |
---|---|---|
1-Day | 0.07% | -0.28% |
1-Month | -5.53% | 15.70% |
1-Year | 16.56% | 6.36% |
3-Year CAGR | 54.01% | -0.90% |
5-Year CAGR | 33.53% | 47.35% |
* Compound Annual Growth Rate
Here are more details on the ALFAVISION S share price and the BALAXI PHARMA share price.
Moving on to shareholding structures...
The promoters of ALFAVISION S hold a 24.8% stake in the company. In case of BALAXI PHARMA the stake stands at 66.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALFAVISION S and the shareholding pattern of BALAXI PHARMA.
Finally, a word on dividends...
In the most recent financial year, ALFAVISION S paid a dividend of Rs 0.1 per share. This amounted to a Dividend Payout ratio of -7.3%.
BALAXI PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of ALFAVISION S, and the dividend history of BALAXI PHARMA.
For a sector overview, read our finance sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.